Live Breaking News & Updates on Sleep Wake Disorders Center

Stay updated with breaking news from Sleep wake disorders center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on. ....

United States , New York , Nordrhein Westfalen , Hans Van Dongen , Mark Jacobson , Darren Opland , Michael Thorpy , Samantha Floam , Johannes Gutenberg , Department Of Neurology , Montefiore Medical Center , Professor At Washington State University , American Academy Of Sleep Medicine , Axsome Therapeutics Inc , Corporate Communications , Drug Administration , Medicine Center , University Witten Herdecke , World Trade Center , Wake Disorders Center , Research Society , Therapeutics Highlights Data , Solriamfetol Demonstrating Improvement , Cognitive Function , Obstructive Sleep Apnea , American Academy ,

Axsome to Present Findings on Solriamfetol's Cognitive Benefits

Axsome will unveil data demonstrating solriamfetol's ability to enhance cognitive functioning in patients with OSA and narcolepsy. ....

Nordrhein Westfalen , Johannes Gutenberg , Michael Thorpy , Solriamfetol Sunosi , Ulf Kallweit , Hans Van Dongen , Samantha Floam , Washington State University , Montefiore Medical Center , Wake Disorders Center , Department Of Neurology , Axsome Therapeutics Inc , Medicine Center , University Witten Herdecke , Axsome Therapeutics , Therapeutics Inc , Washington State , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University , Sleep Wake Disorders Center , Albert Einstein College ,

Avadel to Present Data on Lumryz for Narcolepsy at SLEEP 2024

At SLEEP 2024, Avadel will present new data on Lumryz, the first extended-release, once-nightly formulation of sodium oxybate for narcolepsy. ....

United States , Michaelj Thorpy , Maggie Lavender , Jennifer Gudeman , Drug Administration , Wake Disorders Center At Montefiore , Avadel Pharmaceuticals , Georger Brown Convention Center , Medicine Associates , Risk Evaluation , Mitigation Strategy , Comprehensive Sleep Medicine Associates , Sleep Wake Disorders Center , Albert Einstein College ,

Psychiatry in the News: March 2024

Here are some updates from the world of psychiatry throughout the month of March. ....

Johnj Miller , Michael Thorpy , Pimavanserin Nuplazid , Drug Administration , Albert Einstein College Of Medicine , Wake Disorders Center , Acadia Pharmaceuticals , Montefiore Medical Center , Psychiatric Times , Narcolepsy Meets Primary , Orphan Drug Designation , Sleep Wake Disorders Center , Albert Einstein College , Candidate Pimavanserin Fails , Achieve Primary Efficacy , Star Advanced Therapy ,

Phase 3 Trial of AXS-12 for Narcolepsy Meets Primary Endpoint

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo. ....

Herriot Tabuteau , Michael Thorpy , Wake Disorders Center , Albert Einstein College Of Medicine , Montefiore Medical Center , Orphan Drug Designation , Sleep Wake Disorders Center , Albert Einstein College , Axsome Therapeutics , Accessed March ,